Kezar Life Sciences Files 8-K on Shareholder Matters

Ticker: KZR · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1645666

Kezar Life Sciences, INC. 8-K Filing Summary
FieldDetail
CompanyKezar Life Sciences, INC. (KZR)
Form Type8-K
Filed DateJun 23, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: KZR

TL;DR

Kezar Life Sciences (KZR) filed an 8-K on shareholder votes. Keep an eye on governance.

AI Summary

Kezar Life Sciences, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders as of June 17, 2025. The filing details the company's corporate information, including its principal executive offices located at 4000 Shoreline Court, Suite 300, South San Francisco, California.

Why It Matters

This filing indicates that Kezar Life Sciences is engaging in corporate actions requiring shareholder approval, which could impact the company's strategic direction and governance.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding shareholder matters and does not appear to contain significant new financial or operational risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Kezar Life Sciences' security holders?

The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters within the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 17, 2025.

What is the principal executive office address for Kezar Life Sciences?

The principal executive offices are located at 4000 Shoreline Court, Suite 300, South San Francisco, California 94080.

What is Kezar Life Sciences' IRS Employer Identification Number?

Kezar Life Sciences' IRS Employer Identification Number is 47-3366145.

What is the SIC code for Kezar Life Sciences?

The Standard Industrial Classification code for Kezar Life Sciences is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Kezar Life Sciences, Inc. (KZR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing